Variant report

Variant	nsv579601
Chromosome Location	chr19:42006714-42031592
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:426)
CpG islands
(count:305)
Chromatin interactive
region (count:0)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:426 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF3	chr19:42007044-42007229	K562	blood:	n/a	n/a
2	BACH1	chr19:42016903-42017186	K562	blood:	n/a	n/a
3	BATF	chr19:42027742-42028251	GM12878	blood:	n/a	n/a
4	BATF	chr19:42027836-42028322	GM12878	blood:	n/a	n/a
5	BATF	chr19:42007315-42007464	GM12878	blood:	n/a	n/a
6	BATF	chr19:42022723-42023153	GM12878	blood:	n/a	n/a
7	BCL11A	chr19:42022922-42023098	GM12878	blood:	n/a	n/a
8	BCL3	chr19:42016667-42016907	GM12878	blood:	n/a	n/a
9	BCL3	chr19:42016314-42016648	GM12878	blood:	n/a	n/a
10	BCL3	chr19:42016218-42016628	GM12878	blood:	n/a	n/a
11	BCLAF1	chr19:42027598-42028326	GM12878	blood:	n/a	n/a
12	BHLHE40	chr19:42028460-42028816	GM12878	blood:	n/a	chr19:42028587-42028603 chr19:42028585-42028601
13	BHLHE40	chr19:42007430-42007554	K562	blood:	n/a	n/a
14	BHLHE40	chr19:42022983-42023012	GM12878	blood:	n/a	n/a
15	CBX3	chr19:42007176-42007860	HCT-116	colon:	n/a	n/a
16	CEBPB	chr19:42022705-42022860	HepG2	liver:	n/a	chr19:42022803-42022814
17	CEBPB	chr19:42022688-42022956	K562	blood:	n/a	chr19:42022803-42022814
18	CEBPB	chr19:42022763-42022875	Hela-S3	cervix:	n/a	chr19:42022803-42022814
19	CEBPB	chr19:42022693-42022893	IMR90	lung:	n/a	chr19:42022803-42022814
20	CEBPB	chr19:42022680-42022977	A549	lung:	n/a	chr19:42022803-42022814
21	CEBPB	chr19:42022644-42023024	HepG2	liver:	n/a	chr19:42022803-42022814
22	CTCF	chr19:42023182-42023433	K562	blood:	n/a	n/a
23	CTCF	chr19:42012093-42012154	GM10248	blood:	n/a	chr19:42012118-42012131
24	CTCF	chr19:42028666-42028695	Spleen_OC	spleen:	n/a	chr19:42028667-42028680
25	CTCF	chr19:42027660-42027810	GM12868	blood:	n/a	n/a
26	CTCF	chr19:42028461-42028495	GM13977	blood:	n/a	n/a
27	CTCF	chr19:42023189-42023451	MCF-7	breast:	n/a	n/a
28	CTCF	chr19:42023195-42023492	GM13976	blood:	n/a	n/a
29	CTCF	chr19:42028643-42028695	H1-hESC	embryonic stem cell:	n/a	chr19:42028667-42028680
30	CTCF	chr19:42023146-42023566	GM19239	blood:	n/a	n/a
31	CTCF	chr19:42023124-42023543	GM12892	blood:	n/a	n/a
32	CTCF	chr19:42023210-42023469	HUVEC	blood vessel:	n/a	n/a
33	CTCF	chr19:42026787-42026882	Lung_OC	lung:	n/a	n/a
34	CTCF	chr19:42012545-42012636	GM10248	blood:	n/a	n/a
35	CTCF	chr19:42023190-42023419	Gliobla	brain:	n/a	n/a
36	CTCF	chr19:42023133-42023527	GM19238	blood:	n/a	n/a
37	CTCF	chr19:42023215-42023322	A549	lung:	n/a	n/a
38	CTCF	chr19:42012048-42012061	MCF-7	breast:	n/a	n/a
39	CTCF	chr19:42031234-42031300	Kidney_OC	kidney:	n/a	n/a
40	CTCF	chr19:42023152-42023470	GM10248	blood:	n/a	n/a
41	CTCF	chr19:42023324-42023457	HepG2	liver:	n/a	n/a
42	CTCF	chr19:42028883-42028907	LNCaP	prostate:	n/a	n/a
43	CTCF	chr19:42023178-42023558	Spleen_OC	spleen:	n/a	n/a
44	CTCF	chr19:42028569-42028710	GM19239	blood:	n/a	chr19:42028667-42028680
45	CTCF	chr19:42023156-42023522	Medullo	brain:	n/a	n/a
46	CTCF	chr19:42023166-42023511	GM12891	blood:	n/a	n/a
47	CTCF	chr19:42023282-42023447	Lung_OC	lung:	n/a	n/a
48	CTCF	chr19:42023167-42023292	Hela-S3	cervix:	n/a	n/a
49	CTCF	chr19:42028595-42028728	GM19238	blood:	n/a	chr19:42028667-42028680
50	CTCF	chr19:42023463-42023464	MCF-7	breast:	n/a	n/a

(count:305 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:42026012-42026062	PFSK-1	brain:	n/a
2	chr19:42026012-42026062	U87	brain:	n/a
3	chr19:42026012-42026062	ECC-1	luminal epithelium:	n/a
4	chr19:42007378-42007428	A549	lung:	n/a
5	chr19:42028551-42028601	HUVEC	blood vessel:	n/a
6	chr19:42007378-42007428	HUVEC	blood vessel:	n/a
7	chr19:42026012-42026062	SK-N-MC	brain:	n/a
8	chr19:42027798-42027848	ECC-1	luminal epithelium:	n/a
9	chr19:42031482-42031532	HNPCEpiC	eye:	n/a
10	chr19:42028551-42028601	PrEC	prostate:	n/a
11	chr19:42027798-42027848	ProgFib	skin:	n/a
12	chr19:42007378-42007428	AG10803	skin:	n/a
13	chr19:42031482-42031532	Caco-2	colon:	n/a
14	chr19:42028551-42028601	AG09319	gingival:	n/a
15	chr19:42027798-42027848	BE2_C	brain:	n/a
16	chr19:42007378-42007428	NB4	blood:	n/a
17	chr19:42027798-42027848	LNCaP	prostate:	n/a
18	chr19:42007378-42007428	HCPEpiC	choroid plexus:	n/a
19	chr19:42007378-42007428	PrEC	prostate:	n/a
20	chr19:42031482-42031532	PFSK-1	brain:	n/a
21	chr19:42026012-42026062	HL-60	blood:	n/a
22	chr19:42007378-42007428	LNCaP	prostate:	n/a
23	chr19:42028551-42028601	GM06990	blood:	n/a
24	chr19:42007378-42007428	MCF-7	breast:	n/a
25	chr19:42028551-42028601	NT2-D1	testis:	n/a
26	chr19:42027798-42027848	HRPEpiC	eye:	n/a
27	chr19:42028551-42028601	RPTEC	kidney:	n/a
28	chr19:42007378-42007428	PANC-1	pancreas:	n/a
29	chr19:42027798-42027848	HCT-116	colon:	n/a
30	chr19:42028551-42028601	MCF-7	breast:	n/a
31	chr19:42031482-42031532	BE2_C	brain:	n/a
32	chr19:42026012-42026062	GM12878	blood:	n/a
33	chr19:42028551-42028601	HPAEpiC	pulmonary alveolar:	n/a
34	chr19:42027798-42027848	HIPEpiC	eye:	n/a
35	chr19:42028551-42028601	AoSMC	blood vessel:	n/a
36	chr19:42028551-42028601	HL-60	blood:	n/a
37	chr19:42027798-42027848	U87	brain:	n/a
38	chr19:42031482-42031532	HMEC	breast:	n/a
39	chr19:42027798-42027848	NHBE	bronchial:	n/a
40	chr19:42031482-42031532	ProgFib	skin:	n/a
41	chr19:42026012-42026062	Hepatocyte	liver:	n/a
42	chr19:42028551-42028601	Hepatocyte	liver:	n/a
43	chr19:42007378-42007428	Jurkat	blood:	n/a
44	chr19:42031482-42031532	HRPEpiC	eye:	n/a
45	chr19:42027798-42027848	Hepatocyte	liver:	n/a
46	chr19:42028551-42028601	HNPCEpiC	eye:	n/a
47	chr19:42031482-42031532	IMR90	lung:	fetal
48	chr19:42028551-42028601	GM12878	blood:	n/a
49	chr19:42028551-42028601	AG09309	skin:	n/a
50	chr19:42026012-42026062	GM12891	blood:	n/a

No data

Variant related genes	Relation type
ENSG00000267107	TF binding region
ENSG00000268034	TF binding region
PLEKHA3P1	TF binding region
ENSG00000267107	CpG island
ENSG00000268034	CpG island
PLEKHA3P1	CpG island

Extended variants
information (count: 601 )
Associated
traits (count: 65 )

Variant overlapped rSNPs/rCNVs (count:601 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs16975289	chr19:42006714-42006715	Weak transcription Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs370404682	chr19:42006739-42006740	Weak transcription Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs587698898	chr19:42006756-42006757	Weak transcription Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs77428334	chr19:42006774-42006775	Weak transcription Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs587631872	chr19:42006880-42006881	Bivalent/Poised TSS Enhancers Bivalent Enhancer Active TSS Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs28660293	chr19:42006897-42006898	Bivalent/Poised TSS Enhancers Bivalent Enhancer Active TSS Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs115085959	chr19:42006928-42006929	Bivalent/Poised TSS Enhancers Bivalent Enhancer Active TSS Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs117699420	chr19:42006939-42006940	Bivalent/Poised TSS Enhancers Bivalent Enhancer Active TSS Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs10425322	chr19:42007042-42007043	Bivalent/Poised TSS Enhancers Bivalent Enhancer Active TSS Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs190853665	chr19:42007054-42007055	Bivalent/Poised TSS Enhancers Bivalent Enhancer Active TSS Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs587638765	chr19:42007139-42007140	Bivalent/Poised TSS Enhancers Bivalent Enhancer Active TSS Weak transcription Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
12	rs587695736	chr19:42007140-42007141	Bivalent/Poised TSS Enhancers Bivalent Enhancer Active TSS Weak transcription Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
13	rs115186776	chr19:42007160-42007161	Bivalent/Poised TSS Enhancers Bivalent Enhancer Active TSS Weak transcription Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
14	rs587648256	chr19:42007202-42007203	Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
15	rs138803146	chr19:42007217-42007218	Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
16	rs150071903	chr19:42007229-42007230	Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
17	rs587709753	chr19:42007243-42007244	Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
18	rs79863560	chr19:42007247-42007248	Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
19	rs368214695	chr19:42007248-42007249	Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
20	rs76519523	chr19:42007279-42007280	Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
21	rs587768978	chr19:42007299-42007300	Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
22	rs587663857	chr19:42007309-42007310	Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
23	rs373995871	chr19:42007310-42007311	Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
24	rs587639072	chr19:42007353-42007354	Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
25	rs7259989	chr19:42007428-42007429	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
26	rs138909150	chr19:42007435-42007436	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
27	rs74582199	chr19:42007438-42007439	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
28	rs144756648	chr19:42007470-42007471	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
29	rs183119153	chr19:42007501-42007502	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
30	rs114382575	chr19:42007515-42007516	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
31	rs587726098	chr19:42007527-42007528	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
32	rs587628107	chr19:42007535-42007536	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
33	rs587663001	chr19:42007548-42007549	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
34	rs587741057	chr19:42007551-42007552	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
35	rs587614406	chr19:42007583-42007584	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
36	rs374846566	chr19:42007628-42007629	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
37	rs587693961	chr19:42007672-42007673	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
38	rs587759290	chr19:42007686-42007687	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
39	rs367550091	chr19:42007738-42007739	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
40	rs188248960	chr19:42007745-42007746	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
41	rs587764778	chr19:42007830-42007831	Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
42	rs587664197	chr19:42007850-42007851	Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
43	rs193079472	chr19:42007867-42007868	Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
44	rs7249258	chr19:42007875-42007876	Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
45	rs139621219	chr19:42007923-42007924	Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
46	rs7249512	chr19:42008023-42008024	Enhancers Flanking Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
47	rs376560679	chr19:42008049-42008050	Enhancers Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
48	rs587598725	chr19:42008059-42008060	Enhancers Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
49	rs144180877	chr19:42008161-42008162	Enhancers Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
50	rs146064608	chr19:42008164-42008165	Enhancers Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:65)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Ovarian neoplasms	16753589	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	19029149	CNVD
Breast cancer	20409316	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Genital abnormality	22378287	CNVD
Hypospadia	22378287	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Astrocytoma	22246337	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	22522925	CNVD
early-passage human iPS cells	21368824	CNVD
Schizophrenia	18511947	CNVD

Chromatin state (count:297 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:42004400-42007000	Active TSS	Psoas Muscle	Psoas
2	chr19:42004400-42007200	Active TSS	Adipose Nuclei	Adipose
3	chr19:42004400-42007200	Active TSS	Right Atrium	heart
4	chr19:42004600-42007000	Active TSS	Skeletal Muscle Male	skeletal muscle
5	chr19:42004800-42007000	Active TSS	Left Ventricle	heart
6	chr19:42005000-42007000	Active TSS	Fetal Muscle Leg	muscle
7	chr19:42005200-42006800	Bivalent/Poised TSS	Stomach Smooth Muscle	stomach
8	chr19:42005400-42006800	Weak transcription	Breast Myoepithelial Primary Cells	Breast
9	chr19:42005600-42007200	Flanking Active TSS	HUVEC	blood vessel
10	chr19:42005800-42006800	Active TSS	Fetal Muscle Trunk	muscle
11	chr19:42006000-42006800	Active TSS	Fetal Adrenal Gland	Adrenal Gland
12	chr19:42006000-42007000	Active TSS	Fetal Kidney	kidney
13	chr19:42006000-42007000	Active TSS	Placenta	Placenta
14	chr19:42006600-42006800	Enhancers	K562	blood
15	chr19:42006600-42007000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
16	chr19:42006600-42007400	Weak transcription	Esophagus	oesophagus
17	chr19:42006600-42008200	Flanking Active TSS	A549	lung
18	chr19:42006800-42007000	Enhancers	Breast Myoepithelial Primary Cells	Breast
19	chr19:42006800-42007000	Bivalent Enhancer	HepG2	liver
20	chr19:42006800-42007200	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
21	chr19:42006800-42007200	Flanking Active TSS	K562	blood
22	chr19:42006800-42007400	Weak transcription	Fetal Muscle Trunk	muscle
23	chr19:42006800-42007800	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
24	chr19:42006800-42007800	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
25	chr19:42006800-42008000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
26	chr19:42007000-42007200	Flanking Active TSS	HepG2	liver
27	chr19:42007000-42007600	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
28	chr19:42007000-42007800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
29	chr19:42007000-42007800	Weak transcription	Skeletal Muscle Male	skeletal muscle
30	chr19:42007200-42007400	Weak transcription	Right Atrium	heart
31	chr19:42007200-42007600	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
32	chr19:42007200-42007600	Enhancers	HepG2	liver
33	chr19:42007200-42007600	Enhancers	HUVEC	blood vessel
34	chr19:42007200-42007800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
35	chr19:42007200-42007800	Enhancers	K562	blood
36	chr19:42007200-42008000	Bivalent Enhancer	Adipose Nuclei	Adipose
37	chr19:42007400-42007600	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
38	chr19:42007400-42007600	Enhancers	Fetal Muscle Trunk	muscle
39	chr19:42007400-42007800	Bivalent Enhancer	H9 Derived Neuron Cultured Cells	ES cell derived
40	chr19:42007400-42007800	Enhancers	Esophagus	oesophagus
41	chr19:42007400-42007800	Enhancers	Right Atrium	heart
42	chr19:42007400-42007800	Flanking Active TSS	GM12878-XiMat	blood
43	chr19:42007600-42007800	Flanking Active TSS	ES-WA7 Cell Line	embryonic stem cell
44	chr19:42007600-42007800	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
45	chr19:42007600-42007800	Flanking Active TSS	Fetal Muscle Trunk	muscle
46	chr19:42007600-42007800	Flanking Active TSS	HUVEC	blood vessel
47	chr19:42007600-42007800	Bivalent Enhancer	Monocytes-CD14+_RO01746	blood
48	chr19:42007800-42008000	Enhancers	HUVEC	blood vessel
49	chr19:42008000-42008200	Enhancers	Skeletal Muscle Male	skeletal muscle
50	chr19:42008200-42008400	Bivalent Enhancer	A549	lung

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links